The World Council for Health Presents 5-Tiered Approach to Treating and Suppressing COVID-19 at Home.

    With the barrage of wobbly policies and strategies against COVID-19 imposed by governments across the globe, the World Health Council recently introduced a 5-tiered approach to fight and eliminate the virus from the home level.

    Established on September 22 of this year, the World Health Council is composed of 45 health-focused non-governmental organizations (NGOs) that aims to provide the “latest unbiased scientific guidance” to help frontline health professionals and non-experts alike “make the best health decisions without being forced into a coercive narrative.”

    Remarkably, the World Health Council’s steering committee is made up of distinguished medical and legal experts, namely Dr. Tess Lawrie (United Kingdom), Dr. Jennifer Hibberd (Canada), Shabnam Palesa Mohamed (South Africa), Dr. Zac Cox (United Kingdom), Dr. Tracy Chandler (New Zealand), Dr. Naseeba Kathrada (South Africa), Dr. Mark Trozzi (Canada), Dr. Maria Hubmer- Mogg (Austria), Karen McKenna (Canada), and Anna De Buisseret (United Kingdom).

    The said 5-tiered approach involves focusing on the early treatment of COVID-19 with “simple medicines and therapies “ before the virus has the chance to cause sickness. The World Health Council emphasizes that infection happens when the spike protein of the virus has already spread its toxicity in the system.

    The core essentials of the 5-tiered approach that the World Health Council promotes are as follows:

    1. Support the immune system.

    2. Target the virus.

    3. Reduce inflammation in the body.

    4. Reduce the risk of blood clots.

    5. Provide symptomatic relief for headaches, fever, cough, and similar related disorders that can come with COVID-19 infection.

    Based on the results of extensive research by several scientists and clinicians over the past few months, it has been determined that the manifestation of COVID-19 involves three distinct phases, particularly the Viral Phase, the Inflammation Phase, and the Hyper-inflammation/Clotting Phase.

    The Viral Phase, which typically happens on the first five days of the infection, is characterized by weakness, diarrhea, nausea, loss of taste, loss of smell, sore throat, headache, joint and muscle pain, and fever. The World Health Council stressed that “asymptomatic people are unlikely to transmit the virus.”

    The Inflammation Phase takes place when a person’s immune system is already activated to fight against the SARS-CoV-2 virus. It is normal to experience flu-like symptoms during this stage. Breathlessness, coughing, difficulty breathing, and possibly pneumonia can also be observed in this phase. It usually manifests between the 6th to 10th day of the infection. The World Health Council strongly recommends seeking hospital care if the difficulty in breathing gets worse.

    As to the Hyper-inflammation/Clotting Phase, its symptoms include blood clotting, further breathing difficulties, and chest heaviness, accompanied by pain. This phase is already deemed as severe COVID-19 infection. 

    According to the World Health Council’s guidelines, one of the medicines that global policymakers seem to skip regarding the fight against COVID-19 is Ivermectin. Besides having proven immune-supportive properties, Ivermectin has also been observed to possess antiviral and even anti-inflammatory attributes. 

    These pieces of science-backed evidence mean Ivermectin is a drug that can be utilized from the Viral Phase, the Inflammation Phase, all the way to the Hyper-inflammation/Clotting Phase. Therefore, the World Health Council advises the recommended dose is 0.2 – 0.4 milligrams of Ivermectin per kilogram of body weight per day for early treatment of SARS-CoV-2 infection at home.

    Moreover, the World Health Council recommends consulting a physician before taking Ivermectin for home-based COVID-19 early treatment since Ivermectin also has blood-thinning properties and may cause adverse side effects if improperly used. 

    Unfortunately, most policymakers like the U.S. Food and Drug Administration, the National Institutes of Health (NIH), and the Centers for Disease Control and Prevention (CDC) are still ignoring Ivermectin’s benefits concerning COVID-19 treatment. 

    While Ivermectin has been approved for human use to treat infections caused by some parasitic worms and head lice and skin conditions like rosacea, its potential for eliminating COVID-19 is ignored up to now. It has even been mocked as “horse medicine” by the supporters of the pro-vaccine agenda. 

    No wonder COVID-19 test-positive cases are still on the rise these days despite the roll-out of seemingly pointless vaccines.

    Latest articles


    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here